BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30281364)

  • 1. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
    Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
    Rogala J; Zhou M
    Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
    Agaimy A
    Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
    Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
    Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
    Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
    Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
    Tsai TH; Lee WY
    Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
    Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
    Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
    Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
    Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.
    Gill AJ; Hes O; Papathomas T; Šedivcová M; Tan PH; Agaimy A; Andresen PA; Kedziora A; Clarkson A; Toon CW; Sioson L; Watson N; Chou A; Paik J; Clifton-Bligh RJ; Robinson BG; Benn DE; Hills K; Maclean F; Niemeijer ND; Vlatkovic L; Hartmann A; Corssmit EP; van Leenders GJ; Przybycin C; McKenney JK; Magi-Galluzzi C; Yilmaz A; Yu D; Nicoll KD; Yong JL; Sibony M; Yakirevich E; Fleming S; Chow CW; Miettinen M; Michal M; Trpkov K
    Am J Surg Pathol; 2014 Dec; 38(12):1588-602. PubMed ID: 25025441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.
    Kumar R; Bonert M; Naqvi A; Zbuk K; Kapoor A
    BMC Urol; 2018 Nov; 18(1):109. PubMed ID: 30482207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.
    Ugarte-Camara M; Fernandez-Prado R; Lorda I; Rossello G; Gonzalez-Enguita C; Cannata-Ortiz P; Ortiz A
    Diagn Pathol; 2019 May; 14(1):42. PubMed ID: 31092265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma.
    Gill AJ; Lipton L; Taylor J; Benn DE; Richardson AL; Frydenberg M; Shapiro J; Clifton-Bligh RJ; Chow CW; Bogwitz M
    Pathology; 2013 Dec; 45(7):689-91. PubMed ID: 24150194
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
    Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
    Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
    N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
    Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
    Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.